| Overcoming obstacles in the tumor microenvironment: Recent advancements in nanoparticle delivery for cancer theranostics M Overchuk, G Zheng Biomaterials 156, 217-237, 2018 | 324 | 2018 |
| Photodynamic and photothermal therapies: synergy opportunities for nanomedicine M Overchuk, RA Weersink, BC Wilson, G Zheng ACS nano 17 (9), 7979-8003, 2023 | 123 | 2023 |
| Water-soluble pristine fullerenes C60 increase the specific conductivity and capacity of lipid model membrane and form the channels in cellular plasma membrane S Prylutska, R Bilyy, M Overchuk, A Bychko, K Andreichenko, R Stoika, ... Journal of Biomedical Nanotechnology 8 (3), 522-527, 2012 | 97 | 2012 |
| Tailored theranostic apolipoprotein E3 porphyrin-lipid nanoparticles target glioblastoma MA Rajora, L Ding, M Valic, W Jiang, M Overchuk, J Chen, G Zheng Chemical science 8 (8), 5371-5384, 2017 | 74 | 2017 |
| Rational design of photosynthesis-inspired nanomedicines KM Harmatys, M Overchuk, G Zheng Accounts of chemical research 52 (5), 1265-1274, 2019 | 47 | 2019 |
| Nanotexaphyrin: One-Pot Synthesis of a Manganese Texaphyrin-Phospholipid Nanoparticle for Magnetic Resonance Imaging JM Keca, J Chen, M Overchuk, N Muhanna, CM MacLaughlin, ... Angewandte Chemie International Edition 55, 2016 | 44 | 2016 |
| Tailoring porphyrin conjugation for nanoassembly-driven phototheranostic properties M Overchuk, M Zheng, MA Rajora, DM Charron, J Chen, G Zheng ACS nano 13 (4), 4560-4571, 2019 | 43 | 2019 |
| Nanoparticle‐Enabled Selective Destruction of Prostate Tumor Using MRI‐Guided Focal Photothermal Therapy CS Jin, M Overchuk, L Cui, BC Wilson, RG Bristow, J Chen, G Zheng The Prostate 76 (13), 1169-1181, 2016 | 39 | 2016 |
| Molecular imaging in drug development: Update and challenges for radiolabeled antibodies and nanotechnology I Colombo, M Overchuk, J Chen, RM Reilly, G Zheng, S Lheureux Methods 130, 23-35, 2017 | 38 | 2017 |
| Subtherapeutic photodynamic treatment facilitates tumor nanomedicine delivery and overcomes desmoplasia M Overchuk, KM Harmatys, S Sindhwani, MA Rajora, A Koebel, ... Nano Letters 21 (1), 344-352, 2020 | 33 | 2020 |
| Tuning pharmacokinetics to improve tumor accumulation of a prostate-specific membrane antigen-targeted phototheranostic agent KM Harmatys, M Overchuk, J Chen, L Ding, Y Chen, MG Pomper, ... Bioconjugate chemistry 29 (11), 3746-3756, 2018 | 28 | 2018 |
| Use of porphysomes to detect primary tumour, lymph node metastases, intra-abdominal metastases and as a tool for image-guided lymphadenectomy: proof of concept in endometrial … L Philp, H Chan, M Rouzbahman, M Overchuk, J Chen, G Zheng, ... Theranostics 9 (9), 2727, 2019 | 23 | 2019 |
| Long‐Circulating Prostate‐Specific Membrane Antigen‐Targeted NIR Phototheranostic Agent M Overchuk, MPF Damen, KM Harmatys, MG Pomper, J Chen, G Zheng Photochemistry and Photobiology 96 (3), 718-724, 2020 | 18 | 2020 |
| Targeted Theranostic 111In/Lu-Nanotexaphyrin for SPECT Imaging and Photodynamic Therapy MHY Cheng, M Overchuk, MA Rajora, JWH Lou, Y Chen, MG Pomper, ... Molecular pharmaceutics 19 (6), 1803-1813, 2021 | 13 | 2021 |
| X-ray-activatable photodynamic nanoconstructs M Overchuk, MHY Cheng, G Zheng ACS Central Science 6 (5), 613-615, 2020 | 12 | 2020 |
| Mixed and Matched Metallo‐Nanotexaphyrin for Customizable Biomedical Imaging JM Keca, MS Valic, MHY Cheng, W Jiang, M Overchuk, J Chen, G Zheng Advanced Healthcare Materials 8 (6), 1800857, 2019 | 8 | 2019 |
| Photochemical Targeting of Mitochondria to Overcome Chemoresistance in Ovarian Cancer † BP Rickard, M Overchuk, G Obaid, MK Ruhi, U Demirci, SE Fenton, ... Photochemistry and Photobiology 99 (2), 448-468, 2023 | 7 | 2023 |
| Methods to evaluate changes in mitochondrial structure and function in cancer BP Rickard, M Overchuk, VA Chappell, M Kemal Ruhi, PD Sinawang, ... Cancers 15 (9), 2564, 2023 | 5 | 2023 |
| Investigation of tracheal cell glycoepitopes with eight sialospecific lectins TI Shkandina, OR Dzhura, MO Overchuk Acta Med Leopol (Lviv) 18 (1), 59-65, 2012 | 5 | 2012 |
| Correction to “Targeted Theranostic 111In/Lu-Nanotexaphyrin for SPECT Imaging and Photodynamic Therapy” MHY Cheng, M Overchuk, MA Rajora, JWH Lou, Y Chen, MG Pomper, ... Molecular Pharmaceutics 20 (1), 783-783, 2022 | 2 | 2022 |
Gang ZhengUniversity of TorontoПодтвержден адрес электронной почты в домене uhnres.utoronto.ca
